Vast Majority of Coronavirus Infections Go Undetected
|
By HospiMedica International staff writers Posted on 20 Apr 2020 |
A new study suggests that only 6% of SARS-CoV-2 infections worldwide have been identified, and the actual number of infections is in the tens of millions.
Researchers at the University of Göttingen (Germany) used estimates of COVID-19 mortality and time until death from a recent study published in The Lancet Infectious Diseases (DOI: 10.1016/S1473-3099(20)30243-7) to test the quality of official case records issued by countries. On the day of publication, April 8, 2020, the researchers estimated that in Germany alone there were 460,000 infections, instead of the 71,000 reported officially. Using the same estimation technique, the US would have about 10 million cases today, instead of the 533,000 reported, and Spain would have over five million, and not 180,000.
The researchers suggest that insufficient and delayed testing may explain why some European countries, such as Italy and Spain, are experiencing much higher casualty numbers (relative to reported confirmed cases) than Germany, which has detected an estimated 15.6% of infections, compared to only 3.5% in Italy or 1.7% in Spain. Detection rates are even lower in the United States (about 1.6%) and the United Kingdom (1.2%), two countries that have received widespread criticism from public health experts for their delayed response to the pandemic. In contrast, South Korea appears to have discovered almost half of all its SARS-CoV-2 infections.
Based on these methods, the researchers estimate an overall case fatality ratio of 1.4%, much lower than that of the past SARS and MERS epidemics, but still higher than the estimated case fatality ratio for the H1N1 flu epidemic in 2001. Case fatality ratio also varies with the type of patient assessed, such as severe symptomatic versus mild unreported cases. Moreover, in those aged less than 60 years, it is just 0.32%, compared to 6.4% in those aged 60 or more, to 13% in those who are 80 years old or more.
“These results mean that governments and policy-makers need to exercise extreme caution when interpreting case numbers for planning purposes,” said co-lead author professor of development economics Sebastian Vollmer, PhD. “Such extreme differences in the amount and quality of testing carried out in different countries mean that official case records are largely uninformative and do not provide helpful information.”
“Putting an end to current travel restrictions and social distancing measures will not only require a strong reduction in the transmission of new cases, but also major improvements in the ability of countries to detect new infections to then adopt adequate measures for isolating infected patients and tracing potential contact persons,” concluded Professor Vollmer. “In absence of such measures, the virus might remain undetected again for an extended period of time and a new outbreak is likely just a matter of time.”
Related Links:
University of Göttingen
Researchers at the University of Göttingen (Germany) used estimates of COVID-19 mortality and time until death from a recent study published in The Lancet Infectious Diseases (DOI: 10.1016/S1473-3099(20)30243-7) to test the quality of official case records issued by countries. On the day of publication, April 8, 2020, the researchers estimated that in Germany alone there were 460,000 infections, instead of the 71,000 reported officially. Using the same estimation technique, the US would have about 10 million cases today, instead of the 533,000 reported, and Spain would have over five million, and not 180,000.
The researchers suggest that insufficient and delayed testing may explain why some European countries, such as Italy and Spain, are experiencing much higher casualty numbers (relative to reported confirmed cases) than Germany, which has detected an estimated 15.6% of infections, compared to only 3.5% in Italy or 1.7% in Spain. Detection rates are even lower in the United States (about 1.6%) and the United Kingdom (1.2%), two countries that have received widespread criticism from public health experts for their delayed response to the pandemic. In contrast, South Korea appears to have discovered almost half of all its SARS-CoV-2 infections.
Based on these methods, the researchers estimate an overall case fatality ratio of 1.4%, much lower than that of the past SARS and MERS epidemics, but still higher than the estimated case fatality ratio for the H1N1 flu epidemic in 2001. Case fatality ratio also varies with the type of patient assessed, such as severe symptomatic versus mild unreported cases. Moreover, in those aged less than 60 years, it is just 0.32%, compared to 6.4% in those aged 60 or more, to 13% in those who are 80 years old or more.
“These results mean that governments and policy-makers need to exercise extreme caution when interpreting case numbers for planning purposes,” said co-lead author professor of development economics Sebastian Vollmer, PhD. “Such extreme differences in the amount and quality of testing carried out in different countries mean that official case records are largely uninformative and do not provide helpful information.”
“Putting an end to current travel restrictions and social distancing measures will not only require a strong reduction in the transmission of new cases, but also major improvements in the ability of countries to detect new infections to then adopt adequate measures for isolating infected patients and tracing potential contact persons,” concluded Professor Vollmer. “In absence of such measures, the virus might remain undetected again for an extended period of time and a new outbreak is likely just a matter of time.”
Related Links:
University of Göttingen
Latest Critical Care News
- Ingestible Capsule Monitors Intestinal Inflammation
- Wireless Implantable Sensor Enables Continuous Endoleak Monitoring
- Pulse Oximeter Index Offers Non-Invasive Guides for Fluid Therapy
- Wearable Patch for Early Skin Cancer Detection to Reduce Unnecessary Biopsies
- 'Universal' Kidney to Match Any Blood Type
- Light-Based Technology to Measure Brain Blood Flow Could Diagnose Stroke and TBI
- AI Heart Attack Risk Assessment Tool Outperforms Existing Methods
- Smartphone Imaging System Enables Early Oral Cancer Detection
- Swallowable Pill-Sized Bioprinter Treats GI Tract Injuries

- Personalized Brain “Pacemakers” Could Help Patients with Hard-To-Treat Epilepsy
- Microscopic DNA Flower Robots to Enable Precision Medicine Delivery
- Origami Robots to Deliver Medicine Less Invasively and More Effectively
- Improved Cough-Detection Technology Aids Health Monitoring
- AI Identifies Children in ER Likely to Develop Sepsis Within 48 Hours
- New Radiofrequency Therapy Slows Glioblastoma Growth
- Battery-Free Wireless Multi-Sensing Platform Revolutionizes Pressure Injury Detection
Channels
Surgical Techniques
view channel
Robotic Assistant Delivers Ultra-Precision Injections with Rapid Setup Times
Age-related macular degeneration (AMD) is a leading cause of blindness worldwide, affecting nearly 200 million people, a figure expected to rise to 280 million by 2040. Current treatment involves doctors... Read more
Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
Intracerebral hemorrhage, a type of stroke caused by bleeding deep within the brain, remains one of the most challenging neurological emergencies to treat. Accounting for about 15% of all strokes, it carries... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







